Measles Vaccination in Presence of Measles Antibody May Enhance Child Survival

Background: In trials of early two-dose measles vaccination (MV), with the first dose being given before 9 months of age, vaccination in the presence of maternal antibody reduced mortality 2- to 3-fold compared with MV in the presence of no measles antibody. We tested this finding in two historical...

Descripción completa

Detalles Bibliográficos
Autores principales: Benn, Christine S., Martins, Cesário L., Andersen, Andreas, Fisker, Ane B., Whittle, Hilton C., Aaby, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020693/
https://www.ncbi.nlm.nih.gov/pubmed/32117827
http://dx.doi.org/10.3389/fped.2020.00020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7020693/
https://www.ncbi.nlm.nih.gov/pubmed/32117827
http://dx.doi.org/10.3389/fped.2020.00020

Ejemplares similares